The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
A new report by the European Centres for Disease Control (ECDC) and World Health Organization (WHO) shows that prevention efforts are failing, particularly in Central and Eastern Europe, as the number of people living with HIV in Europe reaches over 2 million for the first time.
New HIV infections among adolescent girls and young women fell by only 6% between 2010 and 2015. This puts the HIV response severely off-track to reach the UNAIDS 2020 Fast-Track Targets.
This World AIDS Day we've chosen ten pivotal events from the history of the HIV epidemic you should know about.
As we mark the 29th World AIDS Day, Sarah Hand says that with enough commitment, political will and funding we have the tools to achieve UNAIDS’ ambitious fast track targets – but only if we recognise the need for a new approach to HIV prevention.
New HIV vaccine trial builds on success of 2009 Thai trial that showed 31.2% effectiveness in preventing HIV.
According to a recent report, 12 million people inject drugs globally, but they are often simply judged, looked down on, condemned or ignored. This has serious health and social consequences for them, their families and their communities – not least in terms of their risk of acquiring or passing on HIV and hepatitis C.
Treatment access gains are to be applauded – but we will get nowhere if we don’t prevent more new infections and reach out to key affected populations.
A new pill technology has the potential to simplify HIV treatment and curb the rise of drug-resistant HIV.
Drug policy based on prohibition hasn't worked. It's time to build on the success of partial-decriminalisation models with an emphasis on health and human rights, says new report.
Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.
People who inject drugs are increasingly left behind in the HIV response, with limited access to harm reduction services that secure their rights and their health.
Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.